NCT06677749 Skeletal Muscle Myokine Response to Acute Eccentric Exercise
| NCT ID | NCT06677749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Skeletal Muscle |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2024-11-15 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2024-11-15 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the acute local skeletal muscle inflammatory response to thigh muscle (quadriceps) eccentric muscle actions. Eccentric muscle actions occur when the muscle is lengthening as it contracts. This is a pilot project to assess the degree of inflammatory biomarkers, called myokines, that are released locally in skeletal muscle tissue after an acute bout of resistance-exercise using a resistance-exercise machine called an isokinetic dynamometer.
Eligibility Criteria
Inclusion Criteria: * 18-35 years old * healthy * recreationally active (\>/= 150 minutes of moderate to vigorous physical activity per week for at least the past three months) Exclusion Criteria: * "yes" answer to the Get Active Questionnaire which screens for health conditions that may affect exercise ability
Contact & Investigator
Stephen M Cornish, PhD
PRINCIPAL INVESTIGATOR
University of Manitoba
Frequently Asked Questions
Who can join the NCT06677749 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Skeletal Muscle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06677749 currently recruiting?
Yes, NCT06677749 is actively recruiting participants. Contact the research team at Stephen.Cornish@umanitoba.ca for enrollment information.
Where is the NCT06677749 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT06677749 clinical trial?
NCT06677749 is sponsored by University of Manitoba. The principal investigator is Stephen M Cornish, PhD at University of Manitoba. The trial plans to enroll 12 participants.